Publications by authors named "I Glisovic Jovanovic"
Article Synopsis
- Forceps delivery is increasingly overlooked in favor of cesarean sections, despite cesarean complications, with concerns primarily focused on safety and long-term effects on children.
- A study involving 49 women in Serbia assessed the neurological outcomes of children born via forceps at age 7, showing a 16.3% incidence of pathological neurological status among newborns.
- Long-term issues were found in 6.4% of cases, highlighting that while forceps delivery is generally safe for neurological development, there are still mild disorders that can arise.
Semaglutide, a glucagon-like peptide 1 receptor agonist, is an antidiabetic that has recently shown promising immunomodulatory and antitumor effects. Breast cancer is the most common type of cancer affecting women worldwide. The aim of this study was to analyze the effects of semaglutide on the antitumor immunity in a 4T1 mouse breast cancer model.
View Article and Find Full Text PDFTwo new complexes of Pd(II), [Pd(L1)Cl]Cl (Pd1) and [Pd(L2)Cl]Cl (Pd2), (where L1 = ,-bis(5-methylthiazol-2-yl)pyridine-2,6-dicarboxamide and L2 = ,-di(benzo[]thiazol-2-yl)pyridine-2.6-dicarboxamide) were synthesized. Characterization of the complexes was performed using elemental analysis, IR, H NMR spectroscopy and MALDI-TOF mass spectrometry.
View Article and Find Full Text PDFHeyde syndrome, marked by aortic stenosis, gastrointestinal bleeding from angiodysplasia, and acquired von Willebrand syndrome, is often underreported. Shear stress from a narrowed aortic valve degrades von Willebrand factor multimers, leading to angiodysplasia formation and von Willebrand factor deficiency. This case report aims to raise clinician awareness of Heyde syndrome, its complexity, and the need for a multidisciplinary approach.
View Article and Find Full Text PDFArticle Synopsis
- A new cytokine called IL-41 is linked to several autoimmune diseases, including rheumatoid arthritis (RA), and this study seeks to evaluate its potential as a biomarker for RA treatment effectiveness and patient responses.
- The research involves 189 patients from a Serbian rheumatology clinic, split into groups based on their treatment: methotrexate alone, methotrexate with TNF inhibitors, or the IL-6 inhibitor tocilizumab.
- Results show that tocilizumab significantly lowers IL-41 levels and improves disease symptoms the most, while smoking is identified as a major predictor of higher IL-41 concentrations in RA patients.